Paracetamol And Phenylephrine Hydrochloride Thornton & Ross Ltd. (Phenylephrine Hydrochloride, Paracetamol)

Paracetamol and Phenylephrine hydrochloride, the active ingredients in Paracetamol And Phenylephrine Hydrochloride Thornton & Ross Ltd., are an analgesic and a decongestant presented as oral tablets for oral use. They relieve mild to moderate pain, reduce fever and alleviate nasal congestion in adults and children.

GNH USA supplies Paracetamol And Phenylephrine Hydrochloride Thornton & Ross Ltd. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Paracetamol and Phenylephrine act together to address pain‑related and nasal‑congestion symptoms associated with common upper‑respiratory conditions.

- Common cold: reduces nasal congestion, headache and fever. - Sinusitis: eases sinus pressure and associated pain. - Influenza‑like illness: provides analgesic relief and decongestant effect.

Paracetamol and Phenylephrine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Dizziness - Headache - Insomnia - Dry mouth - Transient increase in blood pressure

Serious or Rare Side Effects: - Anaphylactic reaction - Severe hepatic injury - Hypertensive crisis - Cardiac arrhythmia - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Severe bronchospasm

When using this combination product, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Hypertension: monitor blood pressure regularly. - Liver disease: use with caution and under medical supervision. - Concomitant MAO inhibitors: avoid due to risk of hypertensive events. - Alcohol consumption: limit intake to reduce hepatic stress. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Paracetamol and Phenylephrine can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs) - Other sympathomimetic agents (e.g., pseudoephedrine) - Additional paracetamol‑containing products (risk of overdose)

Moderate Interactions (Monitor Closely):\n- Antihypertensive drugs (may reduce efficacy) - Antidepressants (especially SSRIs) - Anticoagulants (potential for altered bleeding risk) - CYP450‑modulating agents (may affect paracetamol metabolism)